March 2, 2020 / 1:51 PM / a month ago

BRIEF-Mateon Provides Update On Its Rapid Antiviral Response Program Initially Targeting Covid-19

March 2 (Reuters) - Mateon Therapeutics Inc:

* MATEON PROVIDES UPDATE ON ITS RAPID ANTIVIRAL RESPONSE PROGRAM INITIALLY TARGETING COVID-19

* MATEON THERAPEUTICS - BEEN EVALUATING THERAPEUTIC AND AI PLATFORMS TO AID IN TREATMENT OF CURRENT COVID-19 VIRUS OUTBREAK

* MATEON THERAPEUTICS INC - HAS MADE SIGNIFICANT PROGRESS IN DEPLOYING ITS CLINICAL ASSETS AGAINST COVID-19 VIRUS

* MATEON THERAPEUTICS INC - NEW DIVISION HAS ALREADY IDENTIFIED INITIAL ANTI-VIRAL CANDIDATES AND HAS ENTERED INTO COLLABORATIONS WITH RESEARCHERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below